Seth Judson

@sethjudson.bsky.social

Infectious disease physician-scientist at UCLA studying zoonotic & vector-borne diseases

Mpox continues to spread in many communities. Tecovirimat has activity against orthopoxviruses in vitro. In a phase 3 trial involving patients with acute mpox, tecovirimat showed no evidence of clinical activity. Full STOMP/A5418 trial results and Research Summary: nej.md/4rdlMA9 #MedSky #IDSky

I'm thrilled that today I returned to UCLA as an Assistant Professor-in-Residence in the Division of Infectious Diseases. I’m building an interdisciplinary team focused on globally emerging zoonotic and vector-borne diseases. More info soon! #IDsky #EpiSky #SciSky sethjudson.com/research-ove...

Overview — Seth Judson, MD

An overview of Seth Judson’s research on emerging infectious diseases, environmental contexts of health, and translating these findings for global policymakers and patients

sethjudson.com

Research done at Rocky Mountain Labs has played a pivotal role in responding to infectious disease threats, including vector-borne diseases, Ebola, and COVID-19. It is a special place and has a major impact on the local community. Thinking of colleagues and community members there #IDsky #SciSky

NPR@npr.org · last yr.

Science is an economic driver in Hamilton, Mont., thanks to Rocky Mountain Laboratories, a federal research lab. Now, layoffs and funding cuts are having an impact in this town far from Washington.